Glucotrack (GCTK) Notes Payables (2010 - 2025)
Glucotrack (GCTK) recorded quarterly Notes Payables of $3.2 million in Q4 2025, up 4.98% on a QoQ basis from $3.0 million in Q3 2025, and up 63540.0% year-over-year from N/an in Q4 2024.
Glucotrack (GCTK) Notes Payables (2010 - 2025) Analysis & Trends
Glucotrack has disclosed Notes Payables across 6 years of filings, most recently posting $3.2 million for Q4 2025.
- Quarterly Notes Payables rose 63540.0% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 63540.0% YoY) and the FY2025 annual result came in at $3.2 million, up 63540.0% from the prior year.
- Notes Payables advanced to $3.2 million in Q4 2025, from $3.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $3.2 million in Q4 2025 and troughed at $5000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2014 | 23,838.00 |
| Dec 31, 2012 | 37,427.00 |
| Sep 30, 2012 | 50,980.00 |
| Mar 31, 2011 | 29,890.00 |
| Dec 31, 2010 | 18,843.00 |